Under the terms of the agreement, RXO shareholders are entitled to a mix of cash and stock, with specific ratios of $17.25 and 0.0856 shares of C.H. Robinson common stock per RXO share. Investors may also elect to receive either $30.25 in cash or 0.1992 shares of C.H. Robinson common stock, though these options remain subject to proration. Monteverde & Associates, a firm recognized in the 2025 ISS Securities Class Action Services Report, is evaluating whether these provisions fulfill fiduciary duties to the company’s stakeholders.

Juan Monteverde, head of the firm, has invited RXO common stock owners to review the transaction details for potential discrepancies in valuation. The firm, which operates out of the Empire State Building, emphasizes that this investigation carries no initial cost or obligation for shareholders. Parties seeking further information or wishing to discuss the case may contact the firm directly at (212) 971-1341 or via email.